{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,21]],"date-time":"2026-09-21T10:15:33Z","timestamp":1789985733881,"version":"4.0.1"},"reference-count":53,"publisher":"American Association for Cancer Research (AACR)","issue":"11","content-domain":{"domain":["aacrjournals.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2005,6,1]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>It has been 25 years since the discovery of human T-cell leukemia virus type I (HTLV-I) and its role in adult T-cell leukemia. Here, in brief, we review the current state of our understanding of HTLV-I epidemiology, viral biology, pathogenesis, and treatment. We discuss how HTLV-I may transform cells through destabilization of cellular genomic integrity and induction of cellular tolerance for chromosomal errors.<\/jats:p>","DOI":"10.1158\/0008-5472.can-05-0559","type":"journal-article","created":{"date-parts":[[2005,9,15]],"date-time":"2005-09-15T21:47:30Z","timestamp":1126820850000},"page":"4467-4470","update-policy":"https:\/\/doi.org\/10.1158\/crossmark_policy","source":"Crossref","is-referenced-by-count":37,"title":["Human T-Cell Leukemia Virus Type I at Age 25: A Progress Report"],"prefix":"10.1158","volume":"65","author":[{"given":"Masao","family":"Matsuoka","sequence":"first","affiliation":[{"name":"1Laboratory of Virus Immunology, Institute for Virus Research, Kyoto University, Kyoto, Japan and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kuan-Teh","family":"Jeang","sequence":"additional","affiliation":[{"name":"2Laboratory of Molecular Microbiology, National Institute of Allergy and Infectious Diseases, NIH, Bethesda, Maryland"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1086","published-online":{"date-parts":[[2005,6,1]]},"reference":[{"key":"2022061620111442700_B1","doi-asserted-by":"crossref","unstructured":"Poiesz BJ, Ruscetti FW, Gazdar AF, Bunn PA, Minna JD, Gallo RC. Detection and isolation of type C retrovirus particles from fresh and cultured lymphocytes of a patient with cutaneous T-cell lymphoma. Proc Natl Acad Sci U S A\u20081980; 77: 7415\u20139.","DOI":"10.1073\/pnas.77.12.7415"},{"key":"2022061620111442700_B2","doi-asserted-by":"crossref","unstructured":"Uchiyama T, Yodoi J, Sagawa K, Takatsuki K, Uchino H. Adult T-cell leukemia: clinical and hematologic features of 16 cases. Blood\u20081977; 50: 481\u201392.","DOI":"10.1182\/blood.V50.3.481.bloodjournal503481"},{"key":"2022061620111442700_B3","doi-asserted-by":"crossref","unstructured":"Hinuma Y, Nagata K, Hanaoka M, et al. Adult T-cell leukemia: antigen in an ATL cell line and detection of antibodies to the antigen in human sera. Proc Natl Acad Sci U S A\u20081981; 78: 6476\u201380.","DOI":"10.1073\/pnas.78.10.6476"},{"key":"2022061620111442700_B4","doi-asserted-by":"crossref","unstructured":"Yoshida M, Miyoshi I, Hinuma Y. Isolation and characterization of retrovirus from cell lines of human adult T-cell leukemia and its implication in the disease. Proc Natl Acad Sci U S A\u20081982; 79: 2031\u20135.","DOI":"10.1073\/pnas.79.6.2031"},{"key":"2022061620111442700_B5","doi-asserted-by":"crossref","unstructured":"Arisawa K, Soda M, Endo S, et al. Evaluation of adult T-cell leukemia\/lymphoma incidence and its impact on non-Hodgkin lymphoma incidence in southwestern Japan. Int J Cancer\u20082000; 85: 319\u201324.","DOI":"10.1002\/(SICI)1097-0215(20000201)85:3<319::AID-IJC4>3.0.CO;2-B"},{"key":"2022061620111442700_B6","doi-asserted-by":"crossref","unstructured":"Iga M, Okayama A, Stuver S, et al. Genetic evidence of transmission of human T cell lymphotropic virus type 1 between spouses. J Infect Dis\u20082002; 185: 691\u20135.","DOI":"10.1086\/339002"},{"key":"2022061620111442700_B7","doi-asserted-by":"crossref","unstructured":"Igakura T, Stinchcombe JC, Goon PK, Taylor GP, Weber JN, Griffiths GM, et al. Spread of HTLV-I between lymphocytes by virus-induced polarization of the cytoskeleton. Science\u20082003; 299: 1713\u20136.","DOI":"10.1126\/science.1080115"},{"key":"2022061620111442700_B8","doi-asserted-by":"crossref","unstructured":"Manel N, Kim FJ, Kinet S, Taylor N, Sitbon M, Battini JL. The ubiquitous glucose transporter GLUT-1 is a receptor for HTLV. Cell\u20082003; 115: 449\u201359.","DOI":"10.1016\/S0092-8674(03)00881-X"},{"key":"2022061620111442700_B9","doi-asserted-by":"crossref","unstructured":"Kim FJ, Manel N, Garrido EN, Valle C, Sitbon M, Battini JL. HTLV-1 and -2 envelope SU subdomains and critical determinants in receptor binding. Retrovirology\u20082004; 1: 41.","DOI":"10.1186\/1742-4690-1-41"},{"key":"2022061620111442700_B10","doi-asserted-by":"crossref","unstructured":"Jeang KT, Giam CZ, Majone F, Aboud M. Life, death, and tax: role of HTLV-I oncoprotein in genetic instability and cellular transformation. J Biol Chem\u20082004; 279: 31991\u20134.","DOI":"10.1074\/jbc.R400009200"},{"key":"2022061620111442700_B11","doi-asserted-by":"crossref","unstructured":"Okada M, Jeang KT. Differential requirements for activation of integrated and transiently transfected human T-cell leukemia virus type 1 long terminal repeat. J Virol\u20082002; 76: 12564\u201373.","DOI":"10.1128\/JVI.76.24.12564-12573.2002"},{"key":"2022061620111442700_B12","doi-asserted-by":"crossref","unstructured":"Scoggin KE, Ulloa A, Nyborg JK. The oncoprotein Tax binds the SRC-1-interacting domain of CBP\/p300 to mediate transcriptional activation. Mol Cell Biol\u20082001; 21: 5520\u201330.","DOI":"10.1128\/MCB.21.16.5520-5530.2001"},{"key":"2022061620111442700_B13","doi-asserted-by":"crossref","unstructured":"Yoshida M. Multiple viral strategies of HTLV-1 for dysregulation of cell growth control. Annu Rev Immunol\u20082001; 19: 475\u201396.","DOI":"10.1146\/annurev.immunol.19.1.475"},{"key":"2022061620111442700_B14","doi-asserted-by":"crossref","unstructured":"Azran I, Schavinsky-Khrapunsky Y, Aboud M. Role of Tax protein in human T-cell leukemia virus type-I leukemogenicity. Retrovirology\u20082004; 1: 20.","DOI":"10.1186\/1742-4690-1-20"},{"key":"2022061620111442700_B15","doi-asserted-by":"crossref","unstructured":"Ching YP, Chun AC, Chin KT, Zhang ZQ, Jeang KT, Jin DY. Specific TATAA and bZIP requirements suggest that HTLV-I Tax has transcriptional activity subsequent to the assembly of an initiation complex. Retrovirology\u20082004; 1: 18.","DOI":"10.1186\/1742-4690-1-18"},{"key":"2022061620111442700_B16","doi-asserted-by":"crossref","unstructured":"Ng PW, Iha H, Iwanaga Y, et al. Genome-wide expression changes induced by HTLV-1 Tax: evidence for MLK-3 mixed lineage kinase involvement in Tax-mediated NF-\u03baB activation. Oncogene\u20082001; 20: 4484\u201396.","DOI":"10.1038\/sj.onc.1204513"},{"key":"2022061620111442700_B17","unstructured":"Pise-Masison CA, Radonovich M, Mahieux R, et al. Transcription profile of cells infected with human T-cell leukemia virus type I compared with activated lymphocytes. Cancer Res\u20082002; 62: 3562\u201371."},{"key":"2022061620111442700_B18","doi-asserted-by":"crossref","unstructured":"Jeang KT. Functional activities of the human T-cell leukemia virus type I Tax oncoprotein: cellular signaling through NF-\u03baB. Cytokine Growth Factor Rev\u20082001; 12: 207\u201317.","DOI":"10.1016\/S1359-6101(00)00028-9"},{"key":"2022061620111442700_B19","doi-asserted-by":"crossref","unstructured":"Matsuoka M. Human T-cell leukemia virus type I and adult T-cell leukemia. Oncogene\u20082003; 22: 5131\u201340.","DOI":"10.1038\/sj.onc.1206551"},{"key":"2022061620111442700_B20","doi-asserted-by":"crossref","unstructured":"Grassmann R, Berchtold S, Radant I, Alt M, Fleckenstein B, Sodroski JG, et al. Role of human T-cell leukemia virus type 1 X region proteins in immortalization of primary human lymphocytes in culture. J Virol\u20081992; 66: 4570\u20135.","DOI":"10.1128\/jvi.66.7.4570-4575.1992"},{"key":"2022061620111442700_B21","doi-asserted-by":"crossref","unstructured":"Mortreux F, Gabet AS, Wattel E. Molecular and cellular aspects of HTLV-1 associated leukemogenesis in vivo. Leukemia\u20082003; 17: 26\u201338.","DOI":"10.1038\/sj.leu.2402777"},{"key":"2022061620111442700_B22","doi-asserted-by":"crossref","unstructured":"Ross TM, Narayan M, Fang ZY, Minella AC, Green PL. Human T-cell leukemia virus type 2 tax mutants that selectively abrogate NF\u03baB or CREB\/ATF activation fail to transform primary human T cells. J Virol\u20082000; 74: 2655\u201362.","DOI":"10.1128\/JVI.74.6.2655-2662.2000"},{"key":"2022061620111442700_B23","doi-asserted-by":"crossref","unstructured":"Younis I, Khair L, Dundr M, Lairmore MD, Franchini G, Green PL. Repression of human T-cell leukemia virus type 1 and type 2 replication by a viral mRNA-encoded posttranscriptional regulator. J Virol\u20082004; 78: 11077\u201383.","DOI":"10.1128\/JVI.78.20.11077-11083.2004"},{"key":"2022061620111442700_B24","doi-asserted-by":"crossref","unstructured":"Michael B, Nair AM, Hiraragi H, et al. Human T lymphotropic virus type-1 p30II alters cellular gene expression to selectively enhance signaling pathways that activate T lymphocytes. Retrovirology\u20082004; 1: 39.","DOI":"10.1186\/1742-4690-1-39"},{"key":"2022061620111442700_B25","doi-asserted-by":"crossref","unstructured":"Vogelstein B, Kinzler KW. Cancer genes and the pathways they control. Nat Med\u20082004; 10: 789\u201399.","DOI":"10.1038\/nm1087"},{"key":"2022061620111442700_B26","doi-asserted-by":"crossref","unstructured":"Mulloy JC, Kislyakova T, Cereseto A, et al. Human T-cell lymphotropic\/leukemia virus type 1 Tax abrogates p53-induced cell cycle arrest and apoptosis through its CREB\/ATF functional domain. J Virol\u20081998; 72: 8852\u201360.","DOI":"10.1128\/JVI.72.11.8852-8860.1998"},{"key":"2022061620111442700_B27","doi-asserted-by":"crossref","unstructured":"Haoudi A, Daniels RC, Wong E, Kupfer G, Semmes OJ. Human T-cell leukemia virus-I tax oncoprotein functionally targets a subnuclear complex involved in cellular DNA damage-response. J Biol Chem\u20082003; 278: 37736\u201344.","DOI":"10.1074\/jbc.M301649200"},{"key":"2022061620111442700_B28","doi-asserted-by":"crossref","unstructured":"Kasai T, Iwanaga Y, Iha H, Jeang KT. Prevalent loss of mitotic spindle checkpoint in adult T-cell leukemia confers resistance to microtubule inhibitors. J Biol Chem\u20082002; 277: 5187\u201393.","DOI":"10.1074\/jbc.M110295200"},{"key":"2022061620111442700_B29","doi-asserted-by":"crossref","unstructured":"Kehn K, Deng L, de La FC, et al. The role of cyclin D2 and p21\/waf1 in human T-cell leukemia virus type 1 infected cells. Retrovirology\u20082004; 1: 6.","DOI":"10.1186\/1742-4690-1-6"},{"key":"2022061620111442700_B30","doi-asserted-by":"crossref","unstructured":"Neuveut C, Low KG, Maldarelli F, et al. Human T-cell leukemia virus type 1 Tax and cell cycle progression: role of cyclin D-cdk and p110Rb. Mol Cell Biol\u20081998; 18: 3620\u201332.","DOI":"10.1128\/MCB.18.6.3620"},{"key":"2022061620111442700_B31","doi-asserted-by":"crossref","unstructured":"Liu B, Liang MH, Kuo YL, et al. Human T-lymphotropic virus type 1 oncoprotein tax promotes unscheduled degradation of Pds1p\/securin and Clb2p\/cyclin B1 and causes chromosomal instability. Mol Cell Biol\u20082003; 23: 5269\u201381.","DOI":"10.1128\/MCB.23.15.5269-5281.2003"},{"key":"2022061620111442700_B32","doi-asserted-by":"crossref","unstructured":"Marriott SJ, Lemoine FJ, Jeang KT. Damaged DNA and miscounted chromosomes: human T cell leukemia virus type I tax oncoprotein and genetic lesions in transformed cells. J Biomed Sci\u20082002; 9: 292\u20138.","DOI":"10.1007\/BF02256583"},{"key":"2022061620111442700_B33","doi-asserted-by":"crossref","unstructured":"Tanaka A, Takahashi C, Yamaoka S, Nosaka T, Maki M, Hatanaka M. Oncogenic transformation by the tax gene of human T-cell leukemia virus type I in vitro. Proc Natl Acad Sci U S A\u20081990; 87: 1071\u20135.","DOI":"10.1073\/pnas.87.3.1071"},{"key":"2022061620111442700_B34","doi-asserted-by":"crossref","unstructured":"Furukawa Y, Kubota R, Tara M, Izumo S, Osame M. Existence of escape mutant in HTLV-I tax during the development of adult T-cell leukemia. Blood\u20082001; 97: 987\u201393.","DOI":"10.1182\/blood.V97.4.987"},{"key":"2022061620111442700_B35","doi-asserted-by":"crossref","unstructured":"Tamiya S, Matsuoka M, Etoh K, et al. Two types of defective human T-lymphotropic virus type I provirus in adult T-cell leukemia. Blood\u20081996; 88: 3065\u201373.","DOI":"10.1182\/blood.V88.8.3065.bloodjournal8883065"},{"key":"2022061620111442700_B36","doi-asserted-by":"crossref","unstructured":"Koiwa T, Hamano-Usami A, Ishida T, et al. 5\u2032-long terminal repeat-selective CpG methylation of latent human T-cell leukemia virus type 1 provirus in vitro and in vivo. J Virol\u20082002; 76: 9389\u201397.","DOI":"10.1128\/JVI.76.18.9389-9397.2002"},{"key":"2022061620111442700_B37","doi-asserted-by":"crossref","unstructured":"Yasunaga J, Taniguchi Y, Nosaka K, et al. Identification of aberrantly methylated genes in association with adult T-cell leukemia. Cancer Res\u20082004; 64: 6002\u20139.","DOI":"10.1158\/0008-5472.CAN-04-1422"},{"key":"2022061620111442700_B38","doi-asserted-by":"crossref","unstructured":"Yoshida M, Nosaka K, Yasunaga J, Nishikata I, Morishita K, Matsuoka M. Aberrant expression of the MEL1S gene identified in association with hypomethylation in adult T-cell leukemia cells. Blood\u20082004; 103: 2753\u201360.","DOI":"10.1182\/blood-2003-07-2482"},{"key":"2022061620111442700_B39","doi-asserted-by":"crossref","unstructured":"Nosaka K, Miyamoto T, Sakai T, Mitsuya H, Suda T, Matsuoka M. Mechanism of hypercalcemia in adult T-cell leukemia: overexpression of receptor activator of nuclear factor \u03baB ligand on adult T-cell leukemia cells. Blood\u20082002; 99: 634\u201340.","DOI":"10.1182\/blood.V99.2.634"},{"key":"2022061620111442700_B40","doi-asserted-by":"crossref","unstructured":"Yasunaga J, Sakai T, Nosaka K, et al. Impaired production of naive T lymphocytes in human T-cell leukemia virus type I-infected individuals: its implications in the immunodeficient state. Blood\u20082001; 97: 3177\u201383.","DOI":"10.1182\/blood.V97.10.3177"},{"key":"2022061620111442700_B41","doi-asserted-by":"crossref","unstructured":"Karube K, Ohshima K, Tsuchiya T, et al. Expression of FoxP3, a key molecule in CD4CD25 regulatory T cells, in adult T-cell leukaemia\/lymphoma cells. Br J Haematol\u20082004; 126: 81\u20134.","DOI":"10.1111\/j.1365-2141.2004.04999.x"},{"key":"2022061620111442700_B42","doi-asserted-by":"crossref","unstructured":"Gessain A, Barin F, Vernant JC, et al. Antibodies to human T-lymphotropic virus type-I in patients with tropical spastic paraparesis. Lancet\u20081985; 2: 407\u201310.","DOI":"10.1016\/S0140-6736(85)92734-5"},{"key":"2022061620111442700_B43","doi-asserted-by":"crossref","unstructured":"Nagai M, Osame M. Human T-cell lymphotropic virus type I and neurological diseases. J Neurovirol\u20082003; 9: 228\u201335.","DOI":"10.1080\/13550280390194028"},{"key":"2022061620111442700_B44","doi-asserted-by":"crossref","unstructured":"Kannagi M, Ohashi T, Harashima N, Hanabuchi S, Hasegawa A. Immunological risks of adult T-cell leukemia at primary HTLV-I infection. Trends Microbiol\u20082004; 12: 346\u201352.","DOI":"10.1016\/j.tim.2004.05.005"},{"key":"2022061620111442700_B45","doi-asserted-by":"crossref","unstructured":"Yamada Y, Tomonaga M, Fukuda H, et al. A new G-CSF-supported combination chemotherapy, LSG15, for adult T-cell leukaemia-lymphoma: Japan Clinical Oncology Group Study 9303. Br J Haematol\u20082001; 113: 375\u201382.","DOI":"10.1046\/j.1365-2141.2001.02737.x"},{"key":"2022061620111442700_B46","doi-asserted-by":"crossref","unstructured":"Utsunomiya A, Miyazaki Y, Takatsuka Y, et al. Improved outcome of adult T cell leukemia\/lymphoma with allogeneic hematopoietic stem cell transplantation. Bone Marrow Transplant\u20082001; 27: 15\u201320.","DOI":"10.1038\/sj.bmt.1702731"},{"key":"2022061620111442700_B47","doi-asserted-by":"crossref","unstructured":"Okamura J, Utsunomiya A, Tanosaki R, et al. Allogeneic stem cell transplantation with reduced conditioning intensity as a novel immunotherapy and antiviral therapy for adult T-cell leukemia\/lymphoma. Blood\u20082005; 105: 4143\u20135.","DOI":"10.1182\/blood-2004-11-4193"},{"key":"2022061620111442700_B48","doi-asserted-by":"crossref","unstructured":"Harashima N, Kurihara K, Utsunomiya A, et al. Graft-versus-Tax response in adult T-cell leukemia patients after hematopoietic stem cell transplantation. Cancer Res\u20082004; 64: 391\u20139.","DOI":"10.1158\/0008-5472.CAN-03-1452"},{"key":"2022061620111442700_B49","doi-asserted-by":"crossref","unstructured":"Mitra-Kaushik S, Harding JC, Hess JL, Ratner L. Effects of the proteasome inhibitor PS-341 on tumor growth in HTLV-1 Tax transgenic mice and Tax tumor transplants. Blood\u20082004; 104: 802\u20139.","DOI":"10.1182\/blood-2003-11-3967"},{"key":"2022061620111442700_B50","doi-asserted-by":"crossref","unstructured":"Satou Y, Nosaka K, Koya Y, Yasunaga JI, Toyokuni S, Matsuoka M. Proteasome inhibitor, bortezomib, potently inhibits the growth of adult T-cell leukemia cells both in vivo and in vitro. Leukemia\u20082004; 18: 1357\u201363.","DOI":"10.1038\/sj.leu.2403400"},{"key":"2022061620111442700_B51","unstructured":"Tan C, Waldmann TA. Proteasome inhibitor PS-341, a potential therapeutic agent for adult T-cell leukemia. Cancer Res\u20082002; 62: 1083\u20136."},{"key":"2022061620111442700_B52","doi-asserted-by":"crossref","unstructured":"Zhang M, Zhang Z, Garmestani K, et al. Activating Fc receptors are required for antitumor efficacy of the antibodies directed toward CD25 in a murine model of adult T-cell leukemia. Cancer Res\u20082004; 64: 5825\u20139.","DOI":"10.1158\/0008-5472.CAN-04-1088"},{"key":"2022061620111442700_B53","doi-asserted-by":"crossref","unstructured":"Ishida T, Iida S, Akatsuka Y, et al. The CC chemokine receptor 4 as a novel specific molecular target for immunotherapy in adult T-cell leukemia\/lymphoma. Clin Cancer Res\u20082004; 10: 7529\u201339.","DOI":"10.1158\/1078-0432.CCR-04-0983"}],"container-title":["Cancer Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/aacrjournals.org\/cancerres\/article-pdf\/65\/11\/4467\/2864227\/4467-4470.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/aacrjournals.org\/cancerres\/article-pdf\/65\/11\/4467\/2864227\/4467-4470.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,1,4]],"date-time":"2025-01-04T08:07:47Z","timestamp":1735978067000},"score":1,"resource":{"primary":{"URL":"https:\/\/aacrjournals.org\/cancerres\/article\/65\/11\/4467\/518010\/Human-T-Cell-Leukemia-Virus-Type-I-at-Age-25-A"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,6,1]]},"references-count":53,"journal-issue":{"issue":"11","published-online":{"date-parts":[[2005,6,1]]},"published-print":{"date-parts":[[2005,6,1]]}},"URL":"https:\/\/doi.org\/10.1158\/0008-5472.can-05-0559","relation":{},"ISSN":["0008-5472","1538-7445"],"issn-type":[{"value":"0008-5472","type":"print"},{"value":"1538-7445","type":"electronic"}],"subject":[],"published":{"date-parts":[[2005,6,1]]}}}